X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


PreviousEntry : {9E15A7FF-DCAC-42D8-B4B2-04513F068CAB} | Display Title : Proper Storage for Temperature-Sensitive Drug Products
NextEntry : {B9E9D48E-E336-4173-9E18-06117525CB74} | Display Title : Proper Storage for Temperature-Sensitive Drug Products
来源

1McDougall, C., McKay, G. A., & Fisher, M. Drugs for Diabetes: Part 6 GLP-1 Receptor Agonists. Br. J Cardiol. 2011;18(4):167-169.

2McDougall, C., McKay, G. A., & Fisher, M. Drugs for Diabetes: Part 6 GLP-1 Receptor Agonists. Br. J Cardiol. 2011;18(4):167-169.

3Garber, A. J. Long Acting Glucagon-Like Peptide 1 Receptor Agonists. Diabetes Care 2011 May; 34(Supplement 2): S279-S284. https://doi.org/10.2337/dc11-s231

4Prasad-Reddy, L., and Isaacs, D. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond. Drugs Context. 2015; 4: 212283. Published online 2015 Jul 9. doi:  10.7573/dic.212283

5Cowan & Company. Therapeutic Categories Outlook: Diabetes/Obesity. Equity Research September 2016, p. 514-15.

6McKee, S. (2016, December 6). Novo files once-weekly GLP-1 analogue semaglutide. Retrieved from http://www.pharmatimes.com/news/novo_files_once-weekly_glp-1_analogue_semaglutide_1180190

 

Previous Next
Aileen Kinsella

Aileen Kinsella

Director, Segment Marketing, Pharma

Click here to receive updates on the latest posts on the WestPharma blog